Craft

Advanced
Ind-Swift

Ind-Swift

Stock Price

₹19.6

2024-10-29

Market Capitalization

₹1.1 B

2024-10-29

Revenue

₹5.2 B

FY, 2025

Ind-Swift Summary

Company Summary

Overview
Ind-Swift is a pharmaceutical manufacturing and marketing company. Its product portfolio includes anti-infective, anti-allergy, analgesic, antidepressant, diabetology, and cardiovascular medicines.
Type
Public
Status
Active
Founded
1986
HQ
Chandigarh, IN | view all locations
Website
http://www.indswiftltd.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Gopal Munjal, Managing Director & CEO

    • Sanjeev Rai Mehta, Chairman

      LocationsView all

      3 locations detected

      • Chandigarh, CH HQ

        India

        781, Industrial Area - Phase II

      • Mumbai, MH

        India

        H 2, Western Express Hwy, Navpada, Vile Parle East, Vile Parle

      • Navi Mumbai, MH

        India

        T.T.C. Industrial Area, Sector 2, Pawne

      Ind-Swift Financials

      Summary Financials

      Revenue (FY, 2025)
      ₹5.2B
      Gross profit (FY, 2025)
      ₹3.0B
      Net income (FY, 2025)
      ₹2.8B
      Cash (FY, 2025)
      ₹695.1M
      EBIT (FY, 2025)
      ₹3.3B
      Enterprise value
      $9.1B

      Competitors and Similar Companies

      Compare competitors

      Footer menu

      Product

      Solutions

      Resources

      Company

      © Craft.co 2026
      Share price data provided by IEX